In gout, the key process is not glycoprotein release. It is an inflammatory reaction to deposited monosodium urate (MSU) crystals.
Mechanism of an acute gout flare
Hyperuricemia causes MSU crystals to form and deposit in the joint.
Macrophages ingest the crystals.
Crystals cause lysosomal injury and activate the NLRP3 inflammasome.
NLRP3 activates caspase-1, which converts inactive pro-IL-1β into active IL-1β.
IL-1β promotes endothelial activation and chemokine release, recruiting many neutrophils.
Neutrophils release inflammatory mediators, enzymes, reactive oxygen species, and may form extracellular traps, producing the abrupt painful, red, swollen joint.
Textbook summary: gout is chronic MSU-crystal deposition disease, and flares begin when crystals interact with host cells to trigger acute inflammation. Rheumatology, 2-Volume Set, section “The Gout Flare,” lines 5234-5248.
Where “glycoprotein” may fit
You may mean one of two different things:
P-glycoprotein (P-gp): an ATP-dependent drug transporter, including in renal tubules. It actively secretes certain drugs into urine. It is not the main cause of gout. Drug transport interactions can sometimes alter the handling of medicines used in gout, such as colchicine.
Glycoproteins in inflammation: adhesion molecules and other glycoproteins on leukocytes/endothelium help neutrophils adhere to vessel walls and migrate into the inflamed gouty joint. They support cell recruitment but are not the central initiating mechanism.